On March 12, 2026, investors weighed UiPath’s first full-year profit against slowing growth and divided Wall Street views.
Morgan Stanley analyst Sanjit Singh also trimmed his price target to $17 from $19. ・Analysts say fourth-quarter results met expectations but see limited near-term upside due to modest growth. ・UBS ...